Export byl úspěšný — 

Observational study on quality of life, safety, and effectiveness of first‐line cetuximab plus chemotherapy in KRAS wild‐type metastatic colorectal cancer patients: the ObservEr Study

Cetuximab improves efficacy when added to chemotherapy for metastatic colorectal cancer (mCRC). Effective management of skin reactions from cetuximab improves quality of life (QoL), and treatment compliance in clinical trials. No data are available from real‐world settings. The ObservEr observationa...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cancer Med
Hlavní autoři: Pinto, Carmine, Di Fabio, Francesca, Rosati, Gerardo, Lolli, Ivan R., Ruggeri, Enzo M., Ciuffreda, Libero, Ferrari, Daris, Lo Re, Giovanni, Rosti, Giovanni, Tralongo, Paolo, Ferrara, Raimondo, Alabiso, Oscar, Chiara, Silvana, Ianniello, Giovanni P., Frassoldati, Antonio, Bilancia, Domenico, Campanella, Giovanna A., Signorelli, Carlo, Racca, Patrizia, Benincasa, Elena, Stroppolo, Maria Elena, Di Costanzo, Francesco
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2016
Témata:
Cancer Prevention
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5119983/
https://ncbi.nlm.nih.gov/pubmed/27748041
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.888
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky